Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

6.68USD
8:08pm BST
Change (% chg)

$0.12 (+1.83%)
Prev Close
$6.56
Open
$6.60
Day's High
$6.74
Day's Low
$6.60
Volume
50,675
Avg. Vol
51,233
52-wk High
$11.37
52-wk Low
$5.99

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.49 December 20 Jun 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 6 5 5 4
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.14 2.17 2.17 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 5 0.30 1.50 0.00 0.75
Quarter Ending Sep-19 5 0.32 1.60 0.00 0.80
Year Ending Dec-19 6 1.07 6.40 0.00 3.15
Year Ending Dec-20 6 13.27 79.60 0.00 8.79
Earnings (per share)
Quarter Ending Jun-19 6 -0.49 -0.40 -0.63 -0.64
Quarter Ending Sep-19 6 -0.49 -0.40 -0.66 -0.63
Year Ending Dec-19 6 -2.07 -1.81 -2.58 -2.28
Year Ending Dec-20 6 -1.91 -1.26 -2.24 -2.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-19 0.30 0.00 0.30 100.00
Quarter Ending Dec-18 1.98 0.00 1.98 100.00
Quarter Ending Sep-18 1.08 0.00 1.08 100.00
Quarter Ending Jun-18 1.63 2.38 0.74 45.50
Quarter Ending Mar-18 1.60 1.51 0.09 5.63
Earnings (per share)
Quarter Ending Mar-19 -0.56 -0.59 0.03 -5.73
Quarter Ending Dec-18 -0.37 -0.62 0.25 -69.40
Quarter Ending Sep-18 -0.45 -0.54 0.09 -21.08
Quarter Ending Jun-18 -0.38 -0.46 0.08 -22.34
Quarter Ending Mar-18 -0.44 -0.49 0.05 -12.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 0.30 0.30 0.38 0.30 0.75
Quarter Ending Sep-19 0.32 0.32 0.40 0.32 0.80
Year Ending Dec-19 1.07 1.07 1.28 1.28 3.15
Year Ending Dec-20 13.27 13.27 15.92 15.92 8.79
Earnings (per share)
Quarter Ending Jun-19 -0.49 -0.49 -0.49 -0.48 -0.64
Quarter Ending Sep-19 -0.49 -0.49 -0.49 -0.48 -0.63
Year Ending Dec-19 -2.07 -2.07 -2.07 -2.00 -2.28
Year Ending Dec-20 -1.91 -1.91 -1.86 -1.77 -2.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-19 0 0 0 0
Quarter Ending Sep-19 0 0 0 0
Year Ending Dec-19 0 0 0 0
Year Ending Dec-20 0 0 0 0
Earnings
Quarter Ending Jun-19 0 0 0 0
Quarter Ending Sep-19 0 0 0 0
Year Ending Dec-19 0 0 0 0
Year Ending Dec-20 0 0 0 0